Literature DB >> 17470383

Parthenolide induces significant apoptosis and production of reactive oxygen species in high-risk pre-B leukemia cells.

Susan J Zunino1, Jonathan M Ducore, David H Storms.   

Abstract

We investigated whether parthenolide, the principal bioactive component of the herb feverfew (Tanacetum parthenium) induced apoptosis in pre-B acute lymphoblastic leukemia (ALL) lines, including cells carrying the t(4;11)(q21;q23) chromosomal translocation. Parthenolide induced rapid apoptotic cell death distinguished by loss of nuclear DNA, externalization of cell membrane phosphatidylserine, and depolarization of mitochondrial membranes at concentrations ranging from 5 to 100 microM. Using reactive oxygen species (ROS)-specific dyes, an increase in nitric oxide and superoxide anion was detected in the cells by 4 h after exposure to parthenolide. Parthenolide-induced elevation of hypochlorite anion was observed only in the two t(4;11) lines. These data suggest parthenolide may have potential as a potent and novel therapeutic agent against pre-B ALLs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17470383     DOI: 10.1016/j.canlet.2007.03.002

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  21 in total

1.  The Feverfew plant-derived compound, parthenolide enhances platelet production and attenuates platelet activation through NF-κB inhibition.

Authors:  Julie Sahler; Jamie J Bernard; Sherry L Spinelli; Neil Blumberg; Richard P Phipps
Journal:  Thromb Res       Date:  2011-01-26       Impact factor: 3.944

Review 2.  Development of Anticancer Agents from Plant-Derived Sesquiterpene Lactones.

Authors:  Yulin Ren; Jianhua Yu; A Douglas Kinghorn
Journal:  Curr Med Chem       Date:  2016       Impact factor: 4.530

Review 3.  Parthenolide, a sesquiterpene lactone, expresses multiple anti-cancer and anti-inflammatory activities.

Authors:  Vivek Bhakta Mathema; Young-Sang Koh; Balkrishna Chand Thakuri; Mika Sillanpää
Journal:  Inflammation       Date:  2012-04       Impact factor: 4.092

4.  RIP3 overexpression sensitizes human breast cancer cells to parthenolide in vitro via intracellular ROS accumulation.

Authors:  Can Lu; Li-Yan Zhou; Hui-Jun Xu; Xing-Yu Chen; Zhong-Sheng Tong; Xiao-Dong Liu; Yong-Sheng Jia; Yue Chen
Journal:  Acta Pharmacol Sin       Date:  2014-06-09       Impact factor: 6.150

5.  Bcl-XL, but not Bcl-2, can protect human B-lymphoma cell lines from parthenolide-induced apoptosis.

Authors:  Alan T Yeo; John A Porco; Thomas D Gilmore
Journal:  Cancer Lett       Date:  2011-12-06       Impact factor: 8.679

6.  The NF (Nuclear factor)-κB inhibitor parthenolide interacts with histone deacetylase inhibitors to induce MKK7/JNK1-dependent apoptosis in human acute myeloid leukaemia cells.

Authors:  Yun Dai; Monica L Guzman; Shuang Chen; Li Wang; Sin-Kei Yeung; Xin-Yan Pei; Paul Dent; Craig T Jordan; Steven Grant
Journal:  Br J Haematol       Date:  2010-08-02       Impact factor: 6.998

Review 7.  The role of oxidative stress in anticancer activity of sesquiterpene lactones.

Authors:  Katarzyna Gach; Angelika Długosz; Anna Janecka
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-02-06       Impact factor: 3.000

8.  Withaferin A activates stress signalling proteins in high risk acute lymphoblastic leukemia.

Authors:  Li-Huan Shi; Xi-Jun Wu; Jun-Shan Liu; Yin-Bo Gao
Journal:  Int J Clin Exp Pathol       Date:  2015-12-01

9.  The Dipeptidyl Peptidases 4, 8, and 9 in Mouse Monocytes and Macrophages: DPP8/9 Inhibition Attenuates M1 Macrophage Activation in Mice.

Authors:  Yannick Waumans; Gwendolyn Vliegen; Lynn Maes; Miche Rombouts; Ken Declerck; Pieter Van Der Veken; Wim Vanden Berghe; Guido R Y De Meyer; Dorien Schrijvers; Ingrid De Meester
Journal:  Inflammation       Date:  2016-02       Impact factor: 4.092

10.  ACT001 modulates the NF-κB/MnSOD/ROS axis by targeting IKKβ to inhibit glioblastoma cell growth.

Authors:  Qiuying Li; Yu Sun; Bowen Liu; Jiabo Li; Xin Hao; Weizhi Ge; Xuemei Zhang; Shiqi Bao; Jianmiao Gong; Zhenhuan Jiang; Chuanjiang Qiu; Liqing Zhao; Yapu Zhao; Yue Chen; Xuejun Yang; Yahui Ding; Zhenzhou Wu
Journal:  J Mol Med (Berl)       Date:  2020-01-04       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.